• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

cardiovascular disease

Adam Wainwright St Louis Cardinals baseball
Marketing

Merck, St. Louis Cardinals pitch heart disease awareness push

Merck is stepping up to the plate to raise awareness of the dangers of high LDL cholesterol and how it can increase the risk of ASCVD.
Andrea Park Sep 17, 2025 4:58pm
Heart on futuristic podium with neon lighting

Wegovy tops Zepbound on CV risk reduction in real-world study

Sep 2, 2025 11:33am
valentines day fail

Merck, Bayer's Verquvo posts perplexing trial fail

Sep 2, 2025 11:06am
Mounjaro tirzepatide

Mounjaro measures up to Trulicity in Eli Lilly cardio trial

Jul 31, 2025 8:12am
Amarin Vascepa box

Amarin sells Vascepa's rights in Europe to Recordati for $25M

Jun 24, 2025 11:26am
Rybelsus

Novo's oral GLP-1 Rybelsus cuts heart disease risks

Mar 31, 2025 11:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings